Rosiglitazone: uses, dosing, side effects & brands
Rosiglitazone is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Available as
- Tablet
- Sold as
- Avandia
- Prescription?
- Prescription only
- Generic available?
- Not in our catalog
Every rosiglitazone product we track (1)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
Only one: Avandia.
What rosiglitazone pills look like
Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.
Combination products containing rosiglitazone
A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.
Rosiglitazone and breastfeeding
From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.
Full LactMed record for rosiglitazone: levels in milk, effects in breastfed infants, and the drugs it would consider insteadNo information is available on the clinical use of rosiglitazone during breastfeeding. Rosiglitazone is over 99% protein bound in plasma, so it is unlikely to pass into breastmilk in clinically important amounts. The manufacturer recommends avoiding breastfeeding during rosiglitazone use, so pioglitazone might be a better choice of the drugs in this class for nursing mothers.
National Institute of Child Health and Human Development, record revised May 15, 2026. LactMed states its information is not a substitute for professional judgement.
What people report to the FDA about rosiglitazone
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 2,453 reports naming rosiglitazone, and the FDA flagged 92% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- myocardial infarction708 reports
- cardiac failure congestive491 reports
- cerebrovascular accident308 reports
- coronary artery disease201 reports
- cardiac disorder106 reports
- dyspnoea95 reports
- hypertension67 reports
- renal failure67 reports
Read these as a signal, not a rate. A report does not mean rosiglitazone caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.
Source: openFDA drug/event (FAERS), retrieved July 26, 2026.
Related calculators
Frequently asked questions
Can you take rosiglitazone with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run rosiglitazone against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What forms does rosiglitazone come in?
Across the brands we track, rosiglitazone is currently marketed as tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic rosiglitazone?
We do not currently list a generic-labelled rosiglitazone product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.
Cite this page
- APA
- pharmaranks. (2026, July 24). Rosiglitazone: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/rosiglitazone
- MLA
- “Rosiglitazone: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/rosiglitazone.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for rosiglitazone on DailyMed (NIH) ↗.